Table 4 Discriminatory performance measures for each of the risk models for 5 year risk of developing colorectal cancer in women

From: External validation of risk prediction models for incident colorectal cancer using UK Biobank

 

Colditz

Freedman

Guesmi

Johnson

QCancer10

Tao

Wei Y-S

Wells

Driver a

Ma (simple) a

Ma (cox) a

Total n

n=164 034

n=130 188

n=202 620

n=203 390

n=193 365

n=189 097

n=194 601

n=191 475

n=201 474

n=174 297

n=174 297

Incident CRC

n = 592

n = 562

n = 752

n = 754

n = 714

n = 696

n = 716

n = 713

n = 745

n = 628

n = 628

Top 10%

Sensitivity

12.3

16.5

11.2

19.8

19.0

18.0

11.0

18.9

17.4

19.6

19.3

Specificity

90.0

90.0

90.0

90.0

90.0

90.0

90.0

90.0

90.0

90.0

90.0

LR+

1.23

1.66

1.12

1.00

1.91

1.80

1.10

1.90

1.75

1.97

1.93

LR−

0.97

0.93

0.99

0.98

0.90

0.91

0.99

0.90

0.92

0.89

0.90

PPV (%)

0.4

0.7

0.4

0.4

0.7

0.7

0.4

0.7

0.6

0.7

0.7

NPV (%)

99.6

99.6

99.6

99.6

99.7

99.7

99.6

99.7

99.7

99.7

99.7

Top 20%

Sensitivity

21.5

30.1

28.3

22.9

36.1

33.9

19.3

33.1

30.9

31.2

32.6

Specificity

80.0

80.0

80.0

80.0

80.1

80.1

80.0

80.0

80.0

80.0

80.0

LR+

1.07

1.51

1.42

1.15

1.81

1.70

1.01

1.66

1.55

1.56

1.64

LR−

0.98

0.87

0.90

0.96

0.80

0.83

0.95

0.84

0.86

0.86

0.84

PPV (%)

0.4

0.6

0.5

0.4

0.7

0.6

0.4

0.6

0.6

0.6

0.6

NPV (%)

99.6

99.6

99.7

99.6

99.7

99.7

99.6

99.7

99.7

99.7

99.7

Top 80%

Sensitivity

80.2

86.1

92.7

76.5

93.6

91.4

78.2

93.1

91.9

93.0

92.0

Specificity

20.0

20.0

20.0

20.0

20.1

20.0

20.0

20.0

20.0

20.0

20.0

LR+

1.00

1.08

1.16

0.96

1.17

1.14

0.98

1.16

1.15

1.16

1.15

LR−

0.99

0.69

0.36

1.17

0.32

0.43

1.09

0.34

0.40

0.35

0.40

PPV (%)

0.4

0.5

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

NPV (%)

99.6

99.7

99.9

99.6

99.9

99.8

99.6

99.9

99.9

99.9

99.9

Top 90%

Sensitivity

90.4

94.0

97.2

88.2

97.1

95.1

88.8

96.9

95.7

96.7

95.7

Specificity

10.0

10.0

10.0

10.0

10.0

10.0

10.0

10.0

10.0

10.0

10.0

LR+

1.00

1.04

1.08

0.98

1.08

1.06

0.99

1.08

1.06

1.07

1.06

LR−

0.96

0.60

0.27

1.18

0.29

0.49

1.12

0.31

0.43

0.33

0.43

PPV (%)

0.4

0.5

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

NPV (%)

99.6

99.7

99.9

99.6

99.9

99.8

99.6

99.9

99.8

99.9

99.8

  1. Abbreviations: LR+=positive likelihood ratio; LR−=negative likelihood ratio; NPV=negative predictive value; PPV=positive predictive value.
  2. aModels originally developed only for men.